Understanding Prolotherapy for Osteoarthritis

What is Prolotherapy?

Prolotherapy is a treatment option for osteoarthritis that involves administering injections into or around the articular space to promote tissue regeneration and repair.

Research Focus

Recent studies have explored the potential negative consequences of intra-articular injections and compared them with periarticular injections specifically for knee osteoarthritis treatment.

The Impact of Osteoarthritis

Overview of Osteoarthritis

Osteoarthritis is a degenerative condition prevalent among the aging population. It primarily affects joints, leading to inflammation, pain, and ultimately, a decline in function.

Current Treatment Approaches

Existing treatment modalities include physical therapy, medication, intra-articular steroid injections, and lifestyle modifications aimed at alleviating pain and managing symptoms. In severe instances, total knee arthroplasty, or knee replacement, may be necessary to restore functionality.

Prolotherapy as an Alternative

Mechanism of Prolotherapy

Prolotherapy serves as a new alternative to knee arthroplasty. This technique involves injecting materials either into (intra) or around (peri) the articular space to facilitate joint tissue repair and regeneration. Dextrose is a commonly used injection material known for its ability to stimulate healing in damaged tissues.

Study Findings

Research has indicated significant improvements in swelling, pain, and range of motion following prolotherapy. A key area of debate is whether intra-articular or periarticular injections yield better results. Intra-articular injections raise concerns due to potential risks associated with breaching the joint capsule, although they may allow for better uptake of the injected material.

Recent Study on Injection Methods

Study Overview

A recent study published in the Journal of Pain Research by Rezasoltani and colleagues assessed the efficacy of periarticular versus intra-articular prolotherapy for patients with knee osteoarthritis. The study involved 104 patients with chronic knee osteoarthritis, all above 50 years of age and graded 2 or higher. Participants were divided into two treatment groups: one received periarticular dextrose injections, and the other received intra-articular dextrose injections. Follow-up visits were conducted at 1, 2, 3, 4, and 5 months post-treatment to evaluate pain, disability, and range of motion.

Results of the Study

Patients who underwent periarticular prolotherapy reported reduced pain and knee disability compared to those who received intra-articular injections. The results indicated that periarticular injections led to significantly improved pain scores and enhanced functional movement, including walking and navigating stairs. Additionally, periarticular injections mitigated the risks associated with intra-articular injections, such as infection, hemarthrosis (bleeding into joint spaces), and post-injection pain.

Conclusion

The findings from this study suggest that periarticular injections are more advantageous than intra-articular injections for treating knee osteoarthritis. This method not only yields superior clinical outcomes but also avoids potential adverse effects and complications associated with the intra-articular approach.

References

Rezasoltani, Z., Taheri, M., Mofrad, M. K., & Mohajerani, S. (2017). Periarticular dextrose prolotherapy instead of intra-articular injection for pain and functional improvement in knee osteoarthritis. Journal of Pain Research, Volume 10, 1179-1187. doi:10.2147/jpr.s127633